Icovamenib for type 2 diabetes not reaching glucose goals
Part of Hormones & metabolism clinical trials.
This study tests an investigational pill called icovamenib for people with type 2 diabetes who have not reached their blood sugar targets with current medications. It aims to see if the drug can help improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old.
- Have type 2 diabetes that is not well controlled (HbA1c between 7.5% and 10.5%).
- Take only certain diabetes pills (like metformin, SGLT2 inhibitors, or specific DPP-4 inhibitors) at a steady dose for at least 3 months.
- Have a body mass index (BMI) of 32 or lower.
- Not be using insulin or other certain diabetes medications like GLP-1 receptor agonists.
- Do not have serious kidney, liver, or pancreas conditions, and no personal or family history of certain tumors (MEN1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational pill called icovamenib for people with type 2 diabetes who are already on Ozempic but still have high blood sugar. The goal is to see if adding icovamenib helps lower blood sugar more safely.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.